• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中pS2蛋白阳性、类固醇受体状态与其他预后因素之间的相关性。

Correlation between pS2 protein positivity, steroid receptor status and other prognostic factors in breast cancer.

作者信息

Racca S, Conti G, Pietribiasi F, Stramignoni D, Tampellini M, Valetto M R, Ghezzo F, Di Carlo F

机构信息

Dipartimento di Scienze Cliniche e Biologiche, Facoltà di Medicina, Orbassano, Torino, Italy.

出版信息

Int J Biol Markers. 1995 Apr-Jun;10(2):87-93. doi: 10.1177/172460089501000204.

DOI:10.1177/172460089501000204
PMID:7561244
Abstract

The cytosolic levels of pS2, an estrogen-regulated protein, were measured in 100 cases of primary breast cancer and related to several conventional histological and biochemical prognostic factors. The data were statistically analyzed on the basis of two different cutoff point for pS2: 4 and 11 ng/mg of cytosolic proteins. pS2 positivity (cutoff 11 ng/mg) was shown to be associated with small tumor size (p = 0.05), a higher differentiation grade (p = 0.007) and a smaller number of mitoses (p = 0.004), but not with menopausal status, lymph node involvement, cathepsin D levels, or proliferative activity determined by the monoclonal antibody Ki67. With the cutoff of 4 ng/mg, the statistical significance was confirmed only for the number of mitoses (p = 0.03), which was also the most closely related covariate in multivariate analysis (p = 0.008). As regards steroid receptor status, a significant difference was observed between pS2+ and pS2- cases (Chi-square = 8.9; p = 0.04, cutoff 4 ng/mg). in conclusion, pS2 positivity, being preferentially expressed in hormone-dependent cells and related to other well-known positive markers, may either indicate a good prognosis or predict responsiveness to endocrine treatment.

摘要

在100例原发性乳腺癌患者中检测了雌激素调节蛋白pS2的胞质水平,并将其与几种传统的组织学和生化预后因素进行关联分析。基于pS2的两个不同截断点(4和11 ng/mg胞质蛋白)对数据进行统计学分析。结果显示,pS2阳性(截断值为11 ng/mg)与肿瘤体积小(p = 0.05)、高分化程度(p = 0.007)和较少的有丝分裂数(p = 0.004)相关,但与绝经状态、淋巴结受累情况、组织蛋白酶D水平或由单克隆抗体Ki67测定的增殖活性无关。当截断值为4 ng/mg时,仅在有丝分裂数方面证实了统计学意义(p = 0.03),在多变量分析中这也是最密切相关的协变量(p = 0.008)。关于类固醇受体状态,在pS2阳性和阴性病例之间观察到显著差异(卡方 = 8.9;p = 0.04,截断值为4 ng/mg)。总之,pS2阳性在激素依赖性细胞中优先表达且与其他已知的阳性标志物相关,可能预示着良好的预后或预测对内分泌治疗的反应性。

相似文献

1
Correlation between pS2 protein positivity, steroid receptor status and other prognostic factors in breast cancer.乳腺癌中pS2蛋白阳性、类固醇受体状态与其他预后因素之间的相关性。
Int J Biol Markers. 1995 Apr-Jun;10(2):87-93. doi: 10.1177/172460089501000204.
2
PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.乳腺癌中的PS2——类固醇受体状态的替代或补充工具?446例病例评估
Br J Cancer. 1993 Aug;68(2):374-9. doi: 10.1038/bjc.1993.343.
3
[Cytosolic pS2 levels and cellular proliferation in ER-positive and PgR-positive infiltrating ductal carcinomas of the breast].[乳腺雌激素受体阳性和孕激素受体阳性浸润性导管癌中的细胞溶质pS2水平与细胞增殖]
Rev Esp Med Nucl. 2005 May-Jun;24(3):185-90. doi: 10.1157/13073789.
4
[Analysis of the cytosolic content of the pS2 protein in breast cancer].[乳腺癌中pS2蛋白胞质含量的分析]
Rev Esp Med Nucl. 2002 Feb;21(1):28-33. doi: 10.1016/s0212-6982(02)72029-6.
5
Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptors.原发性乳腺癌活检中pS2和总组织蛋白酶D的免疫放射分析检测:它们与类固醇受体的相关性
Br J Cancer. 1994 Mar;69(3):550-4. doi: 10.1038/bjc.1994.100.
6
Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.纤溶酶原激活物抑制剂-1与原发性乳腺癌的预后
J Clin Oncol. 1994 Aug;12(8):1648-58. doi: 10.1200/JCO.1994.12.8.1648.
7
Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis.PS2和组织蛋白酶D在710例人类原发性乳腺癌中的预后价值:多变量分析
J Clin Oncol. 1993 May;11(5):899-908. doi: 10.1200/JCO.1993.11.5.899.
8
Prediction of relapse and survival in breast cancer patients by pS2 protein status.通过pS2蛋白状态预测乳腺癌患者的复发和生存情况。
Cancer Res. 1990 Jul 1;50(13):3832-7.
9
[Immunohistochemical detection of pS2 protein in paraffin sections of breast carcinoma tissue. Comparison with results of an immunoradiometry assay].[乳腺癌组织石蜡切片中pS2蛋白的免疫组织化学检测。与免疫放射分析结果的比较]
Pathologe. 1995 Jul;16(4):278-84. doi: 10.1007/s002920050102.
10
Effect of steroid receptors, pS2 and cathepsin D on the outcome of elderly breast cancer patients: an exploratory investigation.类固醇受体、pS2和组织蛋白酶D对老年乳腺癌患者预后的影响:一项探索性研究。
Int J Cancer. 1998 Aug 21;79(4):305-11. doi: 10.1002/(sici)1097-0215(19980821)79:4<305::aid-ijc1>3.0.co;2-z.

引用本文的文献

1
H3K27me3 chromatin heterogeneity reveals variable cell responses to estrogen and endocrine treatment.H3K27me3染色质异质性揭示了细胞对雌激素和内分泌治疗的可变反应。
bioRxiv. 2025 Sep 20:2025.09.18.677184. doi: 10.1101/2025.09.18.677184.
2
Trefoil factor 1 in early breast carcinoma: a potential indicator of clinical outcome during the first 3 years of follow-up.三叶因子 1 在早期乳腺癌中的表达:对前 3 年随访期间临床结局的潜在预测指标。
Int J Med Sci. 2014 May 1;11(7):663-73. doi: 10.7150/ijms.8194. eCollection 2014.